Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapyNikita Sharma, Sulagna Banerjee|Journal of Clinical Investigation|2019Cited by 211
O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stabilityNikita Sharma, Sulagna Banerjee|Theranostics|2019Cited by 63
O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancerNikita Sharma, Sulagna Banerjee|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 7